Skip to main content
FinSpry Logo
FinSpry
BWAY logo
BWAY
(NASDAQ)
BrainsWay Ltd.
$14.39-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BrainsWay (BWAY) Stock Price & Financial Analysis

BrainsWay Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.88 - $14.59
52-Week High$18.18
52-Week Low$7.99
Open$14.00
Volume69.98K
Average Volume (3M)142.85K
Market Cap274.61M
Shares Outstanding19.08M
P/E Ratio (TTM)31.15
Forward P/E27.91
Price to Sales (P/S)4.88
Price to Book (P/B)3.62
EV/EBITDA17.72
Revenue (TTM)56.22M
Net Income (TTM)8.82M
Free Cash Flow (TTM)12.72M
EPS (TTM)$0.26
Profit Margin15.68%
Operating Margin10.23%
Return on Equity (ROE)11.63%
Debt to Equity0.09
50-Day MA$15.42
200-Day MA$14.13
52-Week Change25.24%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About BrainsWay

What is the current stock price for BWAY?

As of the latest trading session, BWAY stock trades at $14.39. The 52-week range is $7.99–$18.18, with a day range of $13.88–$14.59.

What is the P/E ratio for BWAY?

BrainsWay's trailing P/E ratio is 31.1, meaning investors pay $31.1 for every $1 of annual earnings. The forward P/E is 27.9, reflecting analyst expectations for future earnings. BrainsWay operates in the Healthcare sector.

Does BWAY pay dividends?

BrainsWay does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BWAY?

Based on 1 analyst, the consensus for BWAY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BWAY?

BrainsWay's market capitalization is $274.6M, classifying it as a micro-cap company. BrainsWay operates in the Healthcare sector within the Medical Devices industry.